Hospital
Dayton Children's Hospital
Dayton Children's Hospital was paid $290.63M by Medicaid between Jan 2018 and Dec 2024, across 620 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.
33Billing provider infoDAYTON CHILDREN'S HOSPITAL
DAYTON, OH 45404
DAYTON, OH 45404
33aNPI1457379448assigned 07/17/2006
33bProvider typeChildren's Hospital
28Total paid$290.63M
24GClaims3,020,929
24DCodes billed620
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Children's Hospital providers in Ohio
Rank by total paid#2 of 7
Median peer was paid$12.53M
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 255,575 | $19.94M | |
| 2019 | 314,909 | $23.38M | |
| 2020 | 231,227 | $26.65M | |
| 2021 | 310,259 | $35.56M | |
| 2022 | 341,840 | $36.85M | |
| 2023 | 843,497 | $73.08M | |
| 2024incomplete | 723,622 | $75.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 254,256 | 221,123 | $37.80M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 274,996 | 237,695 | $37.78M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 10% | 175,786 | 163,664 | $29.93M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.0% | 159,323 | 153,385 | $23.18M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6.1% | 162,110 | 60,686 | $17.77M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 45,562 | 44,392 | $9.97M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.1% | 48,381 | 43,919 | $9.01M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.9% | 4,459 | 4,117 | $8.44M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.3% | 53,843 | 26,839 | $6.75M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 34,362 | 31,442 | $5.61M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 10,992 | 7,746 | $5.53M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 36,439 | 14,960 | $4.88M |
608 more codes
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.6% | 3,188 | $4.62M |
| D2930 | Prefabricated stainless steel crown - primary tooth | 1.3% | 5,173 | $3.91M |
| 90834 | Psychotherapy session, about 45 minutes | 1.0% | 15,167 | $3.02M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 21,440 | $2.66M |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14,598 | $2.43M |
| G0378 | Hospital observation service, per hour | <1% | 25,630 | $2.29M |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 3,926 | $2.22M |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 3,308 | $2.14M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 16,231 | $2.10M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 16,793 | $2.09M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,790 | $2.01M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 8,858 | $1.90M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,703 | $1.70M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,376 | $1.49M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 749 | $1.45M |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,466 | $1.42M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 33,792 | $1.39M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,364 | $1.39M |
| 42830 | <1% | 1,066 | $1.37M | |
| 92587 | <1% | 11,765 | $1.35M | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,465 | $1.29M |
| J2357 | Injection, omalizumab, 5 mg | <1% | 789 | $1.28M |
| 90837 | Psychotherapy session, about an hour | <1% | 6,119 | $1.23M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 4,937 | $1.18M |
| J3590 | Unclassified biologics | <1% | 589 | $1.13M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,761 | $1.02M |
| 95708 | <1% | 783 | $974K | |
| 90839 | <1% | 4,726 | $955K | |
| 95716 | <1% | 717 | $936K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 4,399 | $919K |
| 95782 | <1% | 935 | $915K | |
| 92523 | <1% | 8,929 | $904K | |
| 76770 | <1% | 3,536 | $886K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 2,138 | $884K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 7,397 | $876K |
| D1351 | Sealant - per tooth | <1% | 1,201 | $796K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,009 | $777K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 1,361 | $743K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 5,135 | $732K |
| 92526 | <1% | 5,701 | $693K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,035 | $690K |
| 97165 | <1% | 3,947 | $585K | |
| 25600 | <1% | 1,265 | $575K | |
| 92567 | <1% | 12,605 | $570K | |
| 81229 | <1% | 784 | $552K | |
| D2331 | <1% | 776 | $550K | |
| D2330 | <1% | 858 | $540K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,447 | $505K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 1,915 | $497K |
| 64643 | <1% | 632 | $497K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 44,669 | $487K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,577 | $477K |
| 80053 | Comprehensive metabolic panel | <1% | 31,746 | $457K |
| 96127 | <1% | 3,565 | $457K | |
| 94010 | <1% | 13,603 | $456K | |
| 97162 | <1% | 3,634 | $454K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 4,774 | $450K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,292 | $447K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 37,957 | $446K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,337 | $431K |
| A0434 | Specialty care transport (sct) | <1% | 2,807 | $414K |
| 97161 | <1% | 3,175 | $413K | |
| 87081 | <1% | 33,717 | $409K | |
| 74018 | <1% | 10,499 | $405K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 839 | $392K |
| A0425 | Ground mileage, per statute mile | <1% | 8,975 | $383K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,175 | $370K |
| S0201 | Partial hospitalization services, less than 24 hours, per diem | <1% | 1,488 | $368K |
| 92609 | <1% | 2,797 | $350K | |
| 95700 | <1% | 1,659 | $341K | |
| 90899 | <1% | 2,448 | $321K | |
| 01922 | <1% | 1,050 | $306K | |
| 83655 | <1% | 11,581 | $306K | |
| 12001 | <1% | 1,176 | $300K | |
| 97803 | <1% | 2,100 | $275K | |
| 12011 | <1% | 1,062 | $271K | |
| 92579 | <1% | 3,754 | $260K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,003 | $258K |
| 42821 | <1% | 154 | $255K | |
| 76882 | <1% | 1,989 | $253K | |
| 92610 | <1% | 2,724 | $249K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12,085 | $246K |
| 93325 | <1% | 2,251 | $244K | |
| 97166 | <1% | 1,469 | $236K | |
| 95816 | <1% | 877 | $231K | |
| 93308 | <1% | 458 | $217K | |
| 95819 | <1% | 1,121 | $211K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 814 | $200K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 569 | $198K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 746 | $189K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 37,720 | $189K |
| 26720 | <1% | 391 | $185K | |
| 84439 | <1% | 15,346 | $184K | |
| 41010 | <1% | 141 | $180K | |
| 93304 | <1% | 375 | $179K | |
| 80061 | Lipid panel | <1% | 10,771 | $178K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 552 | $177K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 6,781 | $171K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 424 | $169K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,714 | $168K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20,264 | $168K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 393 | $163K |
| 36415 | Collection of venous blood by venipuncture | <1% | 72,009 | $163K |
| 92552 | <1% | 2,811 | $161K | |
| 54162 | <1% | 149 | $160K | |
| 93976 | <1% | 790 | $160K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 18,550 | $155K |
| 12051 | <1% | 528 | $150K | |
| 94060 | <1% | 1,924 | $149K | |
| 90785 | <1% | 1,858 | $146K | |
| 90461 | <1% | 25,311 | $144K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 35,327 | $142K |
| 97168 | <1% | 837 | $139K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 181 | $138K |
| 67311 | <1% | 57 | $133K | |
| 96367 | <1% | 1,528 | $132K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,964 | $127K |
| 97802 | <1% | 921 | $126K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 303 | $125K |
| 74019 | <1% | 10,584 | $124K | |
| 87430 | <1% | 43,604 | $124K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 459 | $124K |
| 92555 | <1% | 2,724 | $122K | |
| 83525 | <1% | 4,051 | $119K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,609 | $118K |
| 54150 | <1% | 64 | $115K | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 799 | $114K |
| L8613 | Ossicula implant | <1% | 1,722 | $114K |
| 74230 | <1% | 503 | $113K | |
| 82728 | <1% | 9,381 | $110K | |
| D2390 | <1% | 299 | $110K | |
| 76885 | <1% | 709 | $108K | |
| 88262 | <1% | 626 | $107K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 5,646 | $107K |
| 85014 | <1% | 9,098 | $102K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 741 | $100K |
| 95076 | <1% | 351 | $99K | |
| 96112 | <1% | 292 | $98K | |
| 72082 | <1% | 2,545 | $94K | |
| 44970 | <1% | 30 | $89K | |
| 81243 | <1% | 514 | $88K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,238 | $87K |
| 97116 | <1% | 1,927 | $83K | |
| 29075 | <1% | 411 | $83K | |
| 85007 | <1% | 19,599 | $81K | |
| 88230 | <1% | 649 | $80K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,134 | $78K |
| 83516 | <1% | 6,017 | $76K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,920 | $75K |
| 74240 | <1% | 314 | $70K | |
| 73610 | <1% | 4,524 | $70K | |
| 92652 | <1% | 869 | $70K | |
| 43762 | <1% | 306 | $69K | |
| 70491 | <1% | 131 | $69K | |
| 92557 | <1% | 627 | $65K | |
| 73630 | <1% | 4,722 | $64K | |
| 85027 | <1% | 24,487 | $64K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 715 | $63K |
| 29065 | <1% | 334 | $63K | |
| 77072 | <1% | 1,510 | $63K | |
| 92582 | <1% | 1,039 | $62K | |
| 95117 | <1% | 1,665 | $60K | |
| 86140 | <1% | 11,658 | $59K | |
| 87507 | <1% | 711 | $59K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,175 | $58K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 735 | $58K |
| 97164 | <1% | 575 | $56K | |
| 86003 | <1% | 4,058 | $56K | |
| 76000 | <1% | 407 | $56K | |
| 70486 | <1% | 454 | $55K | |
| 73090 | <1% | 4,116 | $54K | |
| 85018 | <1% | 8,600 | $53K | |
| 92611 | <1% | 480 | $51K | |
| 27750 | <1% | 119 | $51K | |
| 64642 | <1% | 858 | $50K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,135 | $50K |
| D1120 | Dental cleaning, child | <1% | 5,720 | $49K |
| 73100 | <1% | 2,679 | $49K | |
| 72141 | <1% | 178 | $48K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 33,213 | $48K |
| 76536 | <1% | 306 | $48K | |
| 92060 | <1% | 1,537 | $47K | |
| 73521 | <1% | 1,836 | $47K | |
| 28470 | <1% | 104 | $47K | |
| 88291 | <1% | 636 | $47K | |
| 82784 | <1% | 5,273 | $47K | |
| 73562 | <1% | 2,605 | $44K | |
| 73130 | <1% | 3,108 | $44K | |
| 74455 | <1% | 218 | $44K | |
| 73590 | <1% | 2,630 | $42K | |
| 26600 | <1% | 90 | $42K | |
| 16020 | <1% | 310 | $40K | |
| 10060 | <1% | 165 | $40K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,132 | $39K |
| 97542 | <1% | 286 | $39K | |
| 73140 | <1% | 2,804 | $39K | |
| 87077 | <1% | 4,698 | $39K | |
| 17250 | <1% | 148 | $38K | |
| 64405 | <1% | 150 | $38K | |
| 82247 | <1% | 2,383 | $37K | |
| 80076 | <1% | 3,163 | $36K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 262 | $36K |
| 86665 | <1% | 4,553 | $36K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 16,470 | $35K |
| 82785 | <1% | 2,164 | $34K | |
| 70360 | <1% | 1,500 | $34K | |
| 82248 | <1% | 4,514 | $33K | |
| 93320 | <1% | 3,129 | $32K | |
| 73070 | <1% | 2,187 | $31K | |
| 29425 | <1% | 154 | $29K | |
| 86308 | <1% | 2,584 | $29K | |
| 82947 | <1% | 2,150 | $29K | |
| 72081 | <1% | 690 | $28K | |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 158 | $26K |
| 49452 | <1% | 75 | $25K | |
| D2332 | <1% | 53 | $25K | |
| 97163 | <1% | 207 | $25K | |
| 80069 | <1% | 1,615 | $25K | |
| 87186 | <1% | 5,021 | $25K | |
| 24640 | <1% | 58 | $25K | |
| 73110 | <1% | 1,009 | $25K | |
| 51600 | <1% | 218 | $24K | |
| 86663 | <1% | 2,349 | $23K | |
| 24530 | <1% | 48 | $23K | |
| 87070 | <1% | 3,231 | $23K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 629 | $23K |
| 81000 | <1% | 6,361 | $23K | |
| 20680 | <1% | 19 | $23K | |
| 23500 | <1% | 41 | $22K | |
| 92556 | <1% | 2,254 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 8,010 | $21K |
| 92522 | <1% | 174 | $21K | |
| 85651 | <1% | 8,392 | $21K | |
| 83735 | <1% | 3,523 | $21K | |
| 95953 | <1% | 38 | $20K | |
| 81003 | <1% | 14,985 | $20K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 444 | $20K |
| 83021 | <1% | 2,120 | $20K | |
| 87806 | <1% | 1,189 | $20K | |
| 97032 | <1% | 210 | $20K | |
| 83993 | <1% | 907 | $20K | |
| 83540 | <1% | 2,137 | $20K | |
| 82977 | <1% | 3,044 | $19K | |
| 86664 | <1% | 2,349 | $19K | |
| 85610 | <1% | 3,194 | $18K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,721 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,159 | $18K |
| 80320 | <1% | 769 | $18K | |
| 84466 | <1% | 2,011 | $18K | |
| 54161 | <1% | 20 | $18K | |
| 90697 | <1% | 1,394 | $18K | |
| 74183 | <1% | 32 | $18K | |
| 73552 | <1% | 1,316 | $17K | |
| 93225 | <1% | 404 | $17K | |
| 72100 | <1% | 850 | $17K | |
| 84146 | <1% | 563 | $17K | |
| 84450 | <1% | 2,325 | $17K | |
| 86376 | <1% | 1,484 | $17K | |
| 73560 | <1% | 947 | $16K | |
| 73030 | <1% | 1,013 | $16K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 921 | $16K |
| 86008 | <1% | 1,270 | $15K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 26 | $15K |
| 93268 | <1% | 336 | $14K | |
| 84460 | <1% | 2,307 | $14K | |
| 73000 | <1% | 844 | $14K | |
| 86900 | <1% | 785 | $14K | |
| 72070 | <1% | 647 | $14K | |
| 86481 | <1% | 509 | $14K | |
| D2335 | <1% | 14 | $14K | |
| 85240 | <1% | 677 | $13K | |
| 85244 | <1% | 620 | $13K | |
| 29405 | <1% | 64 | $13K | |
| 80197 | <1% | 425 | $13K | |
| 92553 | <1% | 211 | $13K | |
| 86592 | <1% | 1,055 | $13K | |
| 76800 | <1% | 75 | $13K | |
| 81001 | <1% | 12,455 | $13K | |
| 84100 | <1% | 3,025 | $12K | |
| 87205 | <1% | 3,326 | $12K | |
| 29515 | <1% | 63 | $12K | |
| 72040 | <1% | 819 | $12K | |
| 94664 | <1% | 1,771 | $12K | |
| 31575 | <1% | 52 | $11K | |
| 87088 | <1% | 2,468 | $11K | |
| 95012 | <1% | 387 | $11K | |
| 76825 | <1% | 285 | $11K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 157 | $11K |
| 86039 | <1% | 509 | $10K | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | <1% | 903 | $10K |
| 84305 | <1% | 723 | $10K | |
| 73060 | <1% | 831 | $10K | |
| 85245 | <1% | 660 | $10K | |
| D2140 | <1% | 14 | $10K | |
| 86800 | <1% | 1,413 | $10K | |
| 29125 | <1% | 137 | $10K | |
| 86850 | <1% | 452 | $10K | |
| 85247 | <1% | 664 | $10K | |
| 90658 | <1% | 1,133 | $10K | |
| 73660 | <1% | 725 | $10K | |
| 81025 | <1% | 10,612 | $10K | |
| 82607 | <1% | 700 | $10K | |
| 76870 | <1% | 175 | $10K | |
| 99219 | <1% | 222 | $9K | |
| 70220 | <1% | 265 | $9K | |
| 83001 | <1% | 661 | $9K | |
| 83721 | <1% | 689 | $9K | |
| 72170 | <1% | 458 | $9K | |
| 90670 | <1% | 1,272 | $9K | |
| 41115 | <1% | 16 | $9K | |
| 90686 | <1% | 872 | $9K | |
| 36416 | <1% | 9,275 | $9K | |
| 85730 | <1% | 3,023 | $9K | |
| 76506 | <1% | 65 | $9K | |
| 86317 | <1% | 566 | $9K | |
| 90378 | <1% | 58 | $9K | |
| 90648 | <1% | 930 | $8K | |
| 86803 | <1% | 644 | $8K | |
| 92511 | <1% | 52 | $8K | |
| 82803 | <1% | 1,309 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,436 | $8K |
| 93321 | <1% | 473 | $8K | |
| 87340 | <1% | 506 | $8K | |
| 73502 | <1% | 277 | $8K | |
| 82670 | <1% | 408 | $8K | |
| 83002 | <1% | 685 | $8K | |
| 86706 | <1% | 478 | $8K | |
| 82397 | <1% | 879 | $8K | |
| 82139 | <1% | 333 | $8K | |
| 81244 | <1% | 42 | $7K | |
| 94799 | <1% | 115 | $7K | |
| 84403 | <1% | 670 | $7K | |
| 88307 | <1% | 39 | $7K | |
| 77075 | <1% | 27 | $7K | |
| 76010 | <1% | 804 | $7K | |
| 82962 | <1% | 3,967 | $7K | |
| 82570 | <1% | 1,260 | $7K | |
| 96101 | <1% | 28 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,475 | $7K |
| 92607 | <1% | 56 | $7K | |
| 12002 | <1% | 30 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 909 | $6K |
| 82550 | <1% | 1,343 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 497 | $6K |
| 97167 | <1% | 27 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 94 | $6K |
| 83690 | <1% | 3,842 | $6K | |
| 77077 | <1% | 424 | $6K | |
| 01999 | <1% | 36 | $6K | |
| 87040 | <1% | 1,864 | $6K | |
| 27786 | <1% | 14 | $6K | |
| 90715 | <1% | 570 | $6K | |
| 74270 | <1% | 25 | $6K | |
| 86160 | <1% | 612 | $5K | |
| 12031 | <1% | 12 | $5K | |
| 96376 | <1% | 1,467 | $5K | |
| 76827 | <1% | 285 | $5K | |
| 73564 | <1% | 275 | $5K | |
| 25560 | <1% | 16 | $5K | |
| 87581 | <1% | 357 | $5K | |
| 87493 | <1% | 181 | $5K | |
| 94644 | <1% | 1,239 | $5K | |
| 87045 | <1% | 234 | $5K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 85 | $5K |
| 85045 | <1% | 3,189 | $5K | |
| 99381 | <1% | 40 | $5K | |
| 99217 | <1% | 166 | $5K | |
| 84145 | <1% | 1,751 | $5K | |
| 25605 | <1% | 20 | $5K | |
| 29705 | <1% | 31 | $5K | |
| 00731 | <1% | 754 | $4K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 106 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 318 | $4K |
| 25565 | <1% | 14 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,932 | $4K |
| 82272 | <1% | 456 | $4K | |
| 86704 | <1% | 332 | $4K | |
| 90633 | <1% | 437 | $4K | |
| 83615 | <1% | 743 | $4K | |
| 96138 | <1% | 12 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 175 | $4K |
| 82627 | <1% | 228 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 30,254 | $4K |
| 90681 | <1% | 485 | $4K | |
| 82533 | <1% | 258 | $4K | |
| 74220 | <1% | 40 | $4K | |
| 29085 | <1% | 18 | $4K | |
| 70250 | <1% | 149 | $4K | |
| 77076 | <1% | 110 | $3K | |
| 87807 | <1% | 2,334 | $3K | |
| 97760 | <1% | 28 | $3K | |
| 00400 | <1% | 379 | $3K | |
| 87529 | <1% | 230 | $3K | |
| 85576 | <1% | 188 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 15,292 | $3K |
| 72146 | <1% | 72 | $3K | |
| 84270 | <1% | 255 | $3K | |
| 87046 | <1% | 277 | $3K | |
| 90723 | <1% | 636 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 402 | $3K |
| 84703 | <1% | 1,537 | $3K | |
| 90674 | <1% | 224 | $3K | |
| 84156 | <1% | 854 | $3K | |
| 31526 | <1% | 22 | $3K | |
| 82540 | <1% | 216 | $3K | |
| 90657 | <1% | 334 | $3K | |
| 83520 | <1% | 393 | $3K | |
| 87338 | <1% | 123 | $3K | |
| 82610 | <1% | 186 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 33,846 | $3K |
| 84550 | <1% | 658 | $3K | |
| 83498 | <1% | 237 | $3K | |
| 82330 | <1% | 828 | $2K | |
| 83789 | <1% | 220 | $2K | |
| 86256 | <1% | 149 | $2K | |
| Q4012 | Cast supplies, short arm cast, pediatric (0-10 years), fiberglass | <1% | 928 | $2K |
| 87177 | <1% | 121 | $2K | |
| 86901 | <1% | 785 | $2K | |
| 82043 | <1% | 792 | $2K | |
| 84681 | <1% | 324 | $2K | |
| 82525 | <1% | 164 | $2K | |
| Q4008 | Cast supplies, long arm cast, pediatric (0-10 years), fiberglass | <1% | 970 | $2K |
| 94770 | <1% | 12 | $2K | |
| 00300 | <1% | 515 | $2K | |
| 69210 | <1% | 560 | $2K | |
| 82017 | <1% | 191 | $2K | |
| 99382 | <1% | 16 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 25 | $2K |
| 82103 | <1% | 174 | $2K | |
| Q4040 | Cast supplies, short leg cast, pediatric (0-10 years), fiberglass | <1% | 272 | $2K |
| 84630 | <1% | 186 | $2K | |
| 82373 | <1% | 159 | $2K | |
| 90677 | <1% | 188 | $2K | |
| 00160 | <1% | 65 | $2K | |
| 88304 | <1% | 2,360 | $2K | |
| 89230 | <1% | 28 | $2K | |
| 94645 | <1% | 115 | $1K | |
| 90661 | <1% | 141 | $1K | |
| 85384 | <1% | 444 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 39,279 | $1K |
| 83605 | <1% | 321 | $1K | |
| 84481 | <1% | 65 | $1K | |
| 00140 | <1% | 346 | $1K | |
| 84484 | <1% | 494 | $1K | |
| Q4014 | Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass | <1% | 338 | $1K |
| 87650 | <1% | 31 | $1K | |
| 82310 | <1% | 231 | $1K | |
| 83020 | <1% | 86 | $1K | |
| 82565 | <1% | 152 | $1K | |
| 82746 | <1% | 243 | $1K | |
| 87800 | <1% | 27 | $1K | |
| 90675 | <1% | 37 | $1K | |
| 82150 | <1% | 827 | $1K | |
| 73620 | <1% | 56 | $1K | |
| 00126 | <1% | 2,358 | $1K | |
| 82010 | <1% | 390 | $1K | |
| 96368 | <1% | 42 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 12,761 | $984.61 |
| 72197 | <1% | 31 | $979.13 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 5,764 | $947.18 |
| 82157 | <1% | 46 | $911.35 | |
| 70160 | <1% | 28 | $894.64 | |
| 80074 | <1% | 108 | $886.56 | |
| 00813 | <1% | 177 | $863.44 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 16,183 | $853.01 |
| 83864 | <1% | 44 | $840.06 | |
| 86355 | <1% | 85 | $789.21 | |
| 73080 | <1% | 47 | $765.06 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 41,066 | $764.21 |
| 84436 | <1% | 87 | $756.21 | |
| 85660 | <1% | 199 | $724.11 | |
| 90840 | <1% | 134 | $706.77 | |
| 84134 | <1% | 58 | $702.20 | |
| 92583 | <1% | 49 | $696.16 | |
| 84446 | <1% | 93 | $672.97 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 22,149 | $646.02 |
| 87427 | <1% | 71 | $638.12 | |
| 80377 | <1% | 418 | $623.32 | |
| 88313 | <1% | 209 | $600.20 | |
| 87185 | <1% | 175 | $592.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,814 | $589.81 |
| 94760 | <1% | 18,893 | $588.49 | |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 507 | $558.23 |
| 80164 | <1% | 33 | $551.12 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 16 | $545.87 |
| 86359 | <1% | 129 | $543.38 | |
| 83695 | <1% | 77 | $523.92 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 27 | $516.34 |
| 84295 | <1% | 649 | $506.88 | |
| 84132 | <1% | 691 | $502.24 | |
| 86360 | <1% | 127 | $494.25 | |
| 90716 | <1% | 55 | $482.50 | |
| 86430 | <1% | 40 | $475.83 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 10,164 | $446.62 |
| 82438 | <1% | 28 | $434.70 | |
| 00840 | <1% | 231 | $431.72 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 321 | $419.98 |
| 69200 | <1% | 41 | $418.94 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,972 | $411.75 |
| 86357 | <1% | 85 | $394.59 | |
| 29105 | <1% | 13 | $376.81 | |
| 82465 | <1% | 84 | $373.65 | |
| 90651 | <1% | 37 | $357.60 | |
| 83519 | <1% | 23 | $335.77 | |
| 84590 | <1% | 68 | $331.58 | |
| 82653 | <1% | 16 | $309.32 | |
| 86231 | <1% | 14 | $306.55 | |
| 87522 | Neg quan hep c or qual rna | <1% | 38 | $298.24 |
| 90696 | <1% | 30 | $289.60 | |
| 90707 | <1% | 52 | $289.45 | |
| 84155 | <1% | 84 | $280.13 | |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | <1% | 378 | $276.69 |
| 90700 | <1% | 40 | $264.05 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 775 | $263.19 |
| 80299 | <1% | 12 | $240.33 | |
| 86225 | <1% | 30 | $236.31 | |
| 40806 | <1% | 13 | $231.09 | |
| 30300 | <1% | 12 | $230.65 | |
| 90710 | <1% | 44 | $228.35 | |
| Q4032 | Cast supplies, long leg cast, pediatric (0-10 years), fiberglass | <1% | 75 | $213.39 |
| 92551 | <1% | 35 | $197.48 | |
| 84300 | <1% | 118 | $185.66 | |
| 83986 | <1% | 14 | $183.52 | |
| 99225 | <1% | 47 | $178.44 | |
| 95250 | <1% | 32 | $175.91 | |
| 90734 | <1% | 29 | $171.60 | |
| 87449 | <1% | 13 | $170.10 | |
| 84075 | <1% | 31 | $166.49 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 878 | $165.47 |
| 84480 | <1% | 14 | $157.38 | |
| 94761 | <1% | 7,078 | $155.64 | |
| 90620 | <1% | 16 | $150.60 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 7,086 | $148.01 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 887 | $147.50 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 992 | $133.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,076 | $133.32 |
| 87385 | <1% | 14 | $132.69 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,689 | $131.59 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,305 | $131.25 |
| 84376 | <1% | 12 | $126.26 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,491 | $122.92 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 7,718 | $121.64 |
| 80360 | <1% | 17 | $118.97 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 806 | $113.26 |
| 88104 | <1% | 135 | $105.62 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,761 | $104.91 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,092 | $104.50 |
| Q4038 | Cast supplies, short leg cast, adult (11 years +), fiberglass | <1% | 150 | $101.70 |
| 85044 | <1% | 133 | $98.28 | |
| Q4006 | Cast supplies, long arm cast, adult (11 years +), fiberglass | <1% | 41 | $94.05 |
| 86644 | <1% | 12 | $92.22 | |
| 90733 | <1% | 26 | $90.35 | |
| 85250 | <1% | 13 | $88.84 | |
| 82390 | <1% | 12 | $77.43 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 1,436 | $74.68 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 1,124 | $69.76 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,893 | $66.12 |
| 84311 | <1% | 205 | $63.09 | |
| 85670 | <1% | 14 | $58.26 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 566 | $56.15 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | <1% | 930 | $48.17 |
| 86645 | <1% | 12 | $46.12 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 194 | $42.25 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 259 | $40.76 |
| 90480 | <1% | 490 | $39.94 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,400 | $38.78 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 142 | $38.04 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 369 | $37.66 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,458 | $32.50 |
| 84378 | <1% | 18 | $30.06 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 25 | $27.36 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 273 | $25.86 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 122 | $22.56 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 390 | $21.24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 144 | $19.74 |
| J9370 | Vincristine sulfate, 1 mg | <1% | 19 | $19.64 |
| 88342 | <1% | 70 | $12.66 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 494 | $9.87 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 416 | $9.22 |
| 80230 | <1% | 44 | $5.93 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 88 | $3.64 |
| 89051 | <1% | 113 | $2.90 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 101 | $2.62 |
| J1836 | Injection, metronidazole, 10 mg | <1% | 46 | $1.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 66 | $0.60 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 894 | $0.34 |
| 00920 | 0% | 705 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 351 | $0.00 |
| 95957 | 0% | 14 | $0.00 | |
| 01820 | 0% | 17 | $0.00 | |
| 69209 | 0% | 78 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 36 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 0% | 482 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 34 | $0.00 |
| 0071A | 0% | 26 | $0.00 | |
| 0124A | 0% | 14 | $0.00 | |
| 00120 | 0% | 92 | $0.00 | |
| 0072A | 0% | 26 | $0.00 | |
| Q4016 | Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass | 0% | 27 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 1,013 | $0.00 |
| C1769 | Guide wire | 0% | 808 | $0.00 |
| 0082A | 0% | 53 | $0.00 | |
| 01480 | 0% | 34 | $0.00 | |
| 87073 | 0% | 18 | $0.00 | |
| 01400 | 0% | 17 | $0.00 | |
| 0081A | 0% | 66 | $0.00 | |
| 0173A | 0% | 92 | $0.00 | |
| J0687 | Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERGMAN, CHRIS (VP, FINANCE, CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Children's Specialty Physicians, INC. | Dayton, OH | $31.76M |
| Children's Home Care of Dayton | Dayton, OH | $6.04M |
| Dayton Children's Hospital | Dayton, OH | $3.52M |
| Children's Home Care of Dayton | Dayton, OH | $1.10M |
| Dayton Children's Hospital | Miamisburg, OH | $347K |
| Children's Anesthesia Group INC | Dayton, OH | $122K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.